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Podocyte depletion is a critical event in glomerular diseases
in general and in the development of focal segmental
glomerulosclerosis in particular. Progenitor cell immigration
is a possible mechanism of podocyte replacement for the
preservation of nephron function since, with rare exception,
mature podocytes are thought to be incapable of replication.
We examined eight paraffin-embedded renal biopsies from
six male recipients of female transplant kidneys for receiver-
derived podocytes. Fluorescent in situ hybridization for the
Y chromosome was combined with immunofluorescence for
the podocyte marker, Wilms tumor-1 antigen. Recipient-
derived podocytes were found in 4 of 8 biopsies representing
3 of the 6 patients. Overall, 5 of the 740 podocytes examined
in the female-donated kidneys were male derived. Our study
suggests that immigrating progenitor cells are able to
replace podocytes in humans; however, the importance of
this process in physiologic and pathologic conditions is
unknown.
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Podocyte depletion is thought to be the key event in the
development of focal and segmental glomerulosclerosis and
subsequent nephron loss.1–3 According to experimental data,
loss of about 20% of podocytes can initiate sclerosis in an
individual glomerulus.4,5
Podocytes can be lost by necrosis,6 apoptosis,7 and detach-
ment from the basement membrane with subsequent urinary
loss.8–13 Relative podocytopenia occurs in glomerular hyper-
trophy, where a stable amount of podocytes becomes insufficient
to cover the expanded glomerular basement membrane.
Besides in focal and segmental glomerulosclerosis, podo-
cyte depletion has been observed in immunoglobulin A
nephropathy,14 passive Heymann nephritis,12 and diabetic
nephropathy.15–19 Thus, podocyte depletion seems to be a
common pathway to end-stage renal failure in different renal
diseases, emphasizing the critical role of the podocyte for the
integrity of the glomerulus as well as the entire nephron.
Taking the severe consequences of podocyte depletion into
account, mechanisms counteracting podocyte loss both in
disease and ‘shedding’ of podocytes in healthy indivi-
duals10,11 should be of tremendous importance. Theoreti-
cally, replacement of podocytes can be achieved by two
mechanisms, namely replication of podocytes and replace-
ment by immigrating progenitor cells.
The possibility of podocyte replication has been the focus
of controversial discussions. Although some data suggest a
limited proliferative potential of mature podocytes in vivo,
describing DNA synthesis without mitosis,20 binucleate
podocytes,21,22 and proliferating cell nuclear antigen accu-
mulation,23,24 most investigators agree that mature podocytes
do not replicate to a measurable extent in vivo.3,6,25–30 This
opinion is supported by experimental data demonstrating
that rat podocytes virtually failed to incorporate thymidine31
even in glomerular hypertrophy in a remnant kidney model.1
Podocyte proliferation occurs only in certain diseases such
as cellular32 and collapsing types of focal and segmental
glomerulosclerosis,33 HIV-associated glomerulopathy,33 and
possibly crescentic glomerulonephritis.34,35 However, podo-
cyte replication in these diseases rather represents dysregu-
lated proliferation linked to an altered phenotype and thus
cannot be considered regenerative replacement.
The second theoretical mechanism counteracting podo-
cyte loss, immigration of progenitor cells with subsequent
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differentiation into podocytes, has only recently come into
focus. Poulsom et al.36 were the first to demonstrate in an in
vivo mouse model that progenitor cells of bone marrow
origin can differentiate into podocytes. Recent reports on
mice models by three different groups support this idea.37–39
Considering the limited to nonexistent proliferative potential
of mature podocytes, this mechanism could potentially play
an important role for the preservation of podocyte numbers
and the integrity of the nephron itself and it could also be
therapeutically interesting.
The aim of this study was to screen inter-sex-transplanted
human kidneys for recipient-derived podocytes, the presence
of which would support the concept that immigrating
progenitor cells are able to replace podocytes in humans.
RESULTS
Control tissue
A double-labeling technique combining fluorescence in situ
hybridization (FISH) and immunofluorescence (IF) was
developed to determine podocyte lineage and gender of an
individual glomerular cell. FISH probes against X- and Y
chromosomes served to determine the gender and thus the
donor or recipient origin of individual cells. IF staining of
Wilms tumor (WT)-1 specifically marked podocyte nuclei in
the glomerular tuft. Using this combined staining method,
male podocytes could be identified in a female kidney by the
presence of a green-fluorescent Y chromosome against the
background of a WT-1-positive, orange-fluorescent podocyte
nucleus. The additional X signal was used as a control of the
FISH in nonpodocyte nuclei. To assess the sensitivity and the
specificity of these methods, normal renal tissue from tumor
nephrectomy specimens was examined. The sensitivity was
calculated as the ratio of podocytes with an identifiable Y
chromosome to all podocytes in male renal tissue. The
specificity of the detection method was defined as the ratio of
podocytes with a Y chromosome in relation to all detected
podocytes in two female control kidneys.
In the first male, control 26 glomeruli with 674 podocytes
were examined. A Y chromosome was found in 36 (5%, s.d. 6%
and coefficient of variation 0.1037 between different glomeruli)
of these 674 podocytes. At least a single Y chromosome
containing podocyte could be found in 20 (77%) of these 26
glomeruli. The second male control specimen consisted of 35
glomeruli with 673 podocytes of which 51 (8%, s.d. 11%,
coefficient of variation 1.208 among different glomeruli)
showed a Y chromosome. At least a single Y chromosome-
positive podocyte was found in 25 (71%) of these 35 glomeruli.
Thus, combining the data from these two male control
specimens, among all 1347 podocytes examined, 87 (6%,
standard deviation of 9%, coefficient of variation of 1.210
among different glomeruli) could be identified as male. Thus
the sensitivity of the method was considered to be about 6%.
The detection method can be regarded to be highly
specific, because no Y chromosome-positive podocytes were
found among the 30 glomeruli and 459 podocytes in the two
female control specimens.
No podocytes with more than one Y chromosome were
found in the male control specimens, making fusion of
immigrating cells with resident podocytes unlikely.
Transplant biopsies
Paraffin-embedded biopsy material (eight specimens) from
female kidneys transplanted into male recipients was
retrieved from the files of the Institute of Pathology and
Neuropathology of the University Hospital of Essen,
Germany. Basic patient and biopsy data are summarized in
Table 1. The biopsies were obtained 23–257 weeks (mean 75
weeks, median 39 weeks) after transplantation. The clinical
data for each biopsy including serum creatinine and dipstick
urinary protein analysis were taken retrospectively from the
patients’ files (Table 2).
All biopsies were subjected to routine histological workup
according to current Banff protocols including immunohisto-
chemical staining of paraffin-embedded tissue for C4d.40,41
Biopsy findings and diagnoses are listed in Table 3.
Importantly, all biopsies lacked endothelial C4d staining
and none of the biopsies showed diagnostic features of
transplant glomerulitis or transplant glomerulopathy. The
results of the combined FISH- and IF staining are
summarized in Table 4. Recipient-derived podocytes were
found in 3 out of 6 patients (see Figure 1 and 2). The Y
chromosome containing podocytes were identified in 4 of the
8 biopsies. In patient 3, recipient-derived podocytes were
visible in both his biopsies (3.1 and 3.2), which were taken 12
weeks apart. In the first biopsy, which was taken 41 weeks
after transplantation, 1 out of 209 podocytes (0.5%) was
identified as recipient-derived, in the second, taken at 53
weeks, 2 out of 209 podocytes were found to be recipient-
derived (1%).
In total, among the 740 podocytes examined in the
biopsies from the male recipients, five were identified as
recipient-derived (0.7%). These recipient-derived podocytes
were found in 4 out of 42 glomeruli. In one glomerulus
(biopsy 3.2) two recipient-derived podocytes could be
demonstrated (Figure 2).
The earliest time point, at which recipient-derived
podocytes were identified, was 26 weeks after transplantation
(biopsy number 4.1).
There were no significant differences regarding clinical or
histomorphological data between the biopsies with and
without recipient-derived podocytes (Tables 1 and 3).
DISCUSSION
Recently, the first studies in animal models of podocyte
replacement by bone marrow transplantation in the heredi-
tary renal diseases diffuse mesangial sclerosis37 and Alport’s
syndrome38,39 have shown promising results. Thus, at least
for mice, the previous one-way concepts of irreversible
podocyte depletion can be expanded to a concept of
podocyte turnover. In this expanded concept, necrosis,
apoptosis, detachment, and also ‘shedding’ in healthy
individuals are negative contributors to this turnover,
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whereas replacement by immigrating progenitor cells is
probably the only positive contributor. The present proof-
of-principle study addresses the question, if this expanded
concept of podocyte turnover with replacement by immi-
grating progenitor cells can be transferred to humans. Indeed
we found podocytes with a Y chromosome in female kidneys
transplanted into male patients. However, there are two
possible explanations for this finding: either fusion of
immigrating cells with resident cells as has been described
in vitro for stem cells42,43 or differentiation into podocytes of
immigrating recipient-derived progenitor cells. Fusion of
immigrating cells and resident podocytes should lead to











1 1.1 14 Cystinosis 257 Absent
2 2.1 9 Membranoproliferative glomerulonephritis 139 Present
3 3.1 4 Renal dysplasia, urethral valves 41 Present
3.2 53 Present
4 4.1 3 Obstructive uropathy 26 Present
5 5.1 2 Renal dysplasia 23 Absent
5.2 37 Absent
6 6.1 16 Obstructive nephropathy due to urethral valves 26 Absent
TX, transplantation.
Table 2 | Clinical data
Patient number Biopsy number Weeks after TX Serum Creatinine mg/dl Proteinuria Recipient-derived podocytes
1 1.1 257 1.33 Negative Absent
2 2.1 139 1.3 Negative Present
3 3.1 41 0.8 Negative Present
3.2 53 0.86 Negative Present
4 4.1 26 0.8 1 Positive Present
5 5.1 23 0.7 Negative Absent
5.2 37 0.95 No data Absent
6 6.1 26 1.13 Negative Absent
TX, transplantation.
Table 3 | Biopsy findings and recipient-derived podocytes
Patient number Biopsy number Weeks after TX Rejection Other diagnoses TAIF
Recipient-derived
podocytes
1 1.1 257 None Acute tubular damage None Absent
2 2.1 139 None Acute tubular damage Mild Present
3 3.1 41 Banff IA Acute CNI toxicity Severe Present
3.2 53 None Acute CNI toxicity Moderate Present
4 4.1 26 None Acute tubular damage Mild Present
5 5.1 23 Banff IA None Mild Absent
5.2 37 None Acute tubular damage None Absent
6 6.1 26 None Acute CNI-toxicity None Absent
CNI, calcineurin inhibitor; TAIF, tubular atrophy and interstitial fibrosis; TX, transplantation.













1 1.1 2a 32 0 0
2 2.1 6 119 1 1
3 3.1 9 209 1 1
3.2 14 205 2 1
4 4.1 1 12 1 1
5 5.1 5 86 0 0
5.2 2 26 0 0
6 6.1 3a 51 0 0
aTwo sections examined.
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polyploidy with numerically abnormal sets of sex
chromosomes in the male controls. No podocyte with more
than one Y chromosome was found in the male control
specimens, therefore fusion of immigrating cells with resident
podocytes as an alternative explanation for our findings
appears less likely. Thus, our findings suggest that immigrat-
ing progenitor cells can differentiate into podocytes also in
humans.
The present proof-of-principle study is limited by the low
sensitivity of about 6% and the high s.d. of 9% for the
detection of male podocytes; accordingly, quantitative
interpretation of the present data has to be performed
cautiously. A recent study on bone marrow-transplanted
mice had detection rates for donor-derived podocytes of 80%
using a similar method of WT-1-IF and Y-chromosome
FISH.37 The lower sensitivity in this study can likely be
explained by DNA decay due to the probably longer storage
time of our transplant biopsies of up to 3 years. We were not
able to obtain FISH signals in biopsies older than 3 years.
Also the thickness of the paraffin sections can cause
considerable differences in the sensitivity of the Y-chromo-
some in situ hybridization with thicker sections offering a
greater sensitivity. We used thin 3 mm paraffin sections to
eliminate nuclear overlap, which is of particular concern in
glomeruli. In a previous study with a detection rate of about
33% for male tubular epithelial cells,44 5 mm sections were
used (M Mengel, personal communication).
The rate at which podocytes are replaced by immigrating
progenitor cells is probably very low. In his recent study,
Guo et al.37 found 0.9% donor-derived podocytes in a
mouse model of bone marrow transplantation after 8–16
weeks (compared to a mean of 75 weeks in our study).
Considering the low sensitivity and the high s.d. of the
test method in our study, estimating the rate of podocyte
turnover by dividing the ratio of recipient-derived podocytes
by the sensitivity of the test method does not appear to
be meaningful. Further studies with refined methods are
needed to calculate the rate of this turnover and to see if this
rate is high enough to significantly contribute to podocyte
regeneration.
The question, which precise type of the immigrating
stem cells are able to replace podocytes, obviously cannot
be answered from the present data. Poulsom, Guo,
Sugimoto, and Prodromidi36–39 have shown in mice
models that stem cells originating from bone marrow
transplants are able to replace podocytes. Recently,
Perry et al.45 have demonstrated that CD9þ CD44þ
CD45 bone marrow-derived mesenchymal stem cells from
dogs can differentiate into podocytes when cultured on NC1
hexamers of collagen type IV. Together, these experimental
findings suggest that bone marrow-derived mesenchymal
stem cells may also be capable to replace podocytes in
humans. Again, further studies are needed to show, if
mesenchymal stem cells indeed replace podocytes in vivo and
if other stem cell types (e.g. hematopoietic stem cells or
intrarenal stem cells) may also contribute to podocyte
replacement.
Apart from the general implications for podocyte
physiology, replacement of podocytes by immigrating
progenitor cells might also bear implications for transplant
pathophysiology. In renal transplants given to patients with
hereditary podocytopathies, replacement of podocytes with
the genetically defective progenitor cells of the recipient
would have an obviously detrimental effect.
Figure 2 | Recipient-derived podocytes from patient 3, biopsy 3.2,
female donor, and male recipient. Two recipient-derived
podocytes (small frames) can be recognized by the presence of
a Y chromosome (green) in a WT-1-positive (red) podocyte nucleus.
X chromosomes are also marked in red; nuclei are marked in blue.
Insets in the top left and right corner show details from the
corresponding small frames. Combined FISH for X- and Y
chromosomes and IF for WT-1, counterstained with 40,60-diamidino-2-
phenylindole. Original magnification:  600, oil immersion.
86 68mm (300 300 d.p.i.).
Figure 1 | Recipient-derived podocyte from patient 2, biopsy 2.1,
female donor, and male recipient. A recipient-derived podocyte
(small frame) can be recognized by the presence of a Y chromosome
(green) in a WT-1-positive (red) podocyte nucleus. X chromosomes
are also marked in red; nuclei are marked in blue. The inset in the top
right corner shows details from the corresponding small frame.
Combined FISH for X- and Y chromosomes and IF for WT-1,
counterstained with 40,60-diamidino-2-phenylindole. Original
magnification  600, oil immersion. 86 68 mm (300 300 d.p.i.).
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MATERIALS AND METHODS
After dewaxing in xylol and rehydration in graded ethanols, the
3-mm thick paraffin sections from tissue fixed in buffered formalin
were digested with protease P5147 (Sigma-Aldrich, St Louis, MO,
USA). For FISH of X- and Y chromosomes, the CEP X/Y kit
(Vysis, Downers Grove, IL, USA) was used. This kit labels Y
chromosomes with a green-fluorescent signal and X chromosomes
with an orange-fluorescent signal. The combined kit was used,
because X chromosome signals outside of the glomeruli served
as a quality control. DNA was melted for 10 min at 731C.
Hybridization was allowed for 24 h at 371C. Sections were washed
following manufacturers’ instructions and subsequently stained
for WT-1.
The mouse monoclonal anti-WT-1 antibody M3561 (DakoCy-
tomation, Carpinteria, CA, USA) was chosen to identify podocyte
nuclei by IF. Bound primary antibody was marked with a Cy3-
conjugated (orange-fluorescent) secondary antibody (no. 715-166-
150, Jackson ImmunoResearch, West Grove, PA, USA). Nuclei were
counterstained with the blue-fluorescent 40,60-diamidino-2-pheny-
lindole.
Normal renal tissue from tumor nephrectomy specimens was
taken to establish the sensitivity and specificity of the detection
method for male podocytes. The first male control specimen was
from a 38-year old patient and the second one from a 36-year-old
patient. The two female control specimens were from 61- and 82-
year-old patients.
A digital photograph was taken from each glomerulus under oil
immersion. Color levels were adjusted with Photoshop CS (Adobe
Systems, San Jose, CA, USA) on a Macintosh G4 system (Apple
Computers, Cupertino, CA, USA).
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